Publications
27.09.2018
Key considerations for payer scientific advice

This research highlights the variability regarding the scientific advice submission processes and sc...

Read more
Case Studies
21.09.2018
Payer value proposition development

Understanding payer value and evidence requirements to secure pricing and reimbursement for a novel ...

Read more
Publications
20.09.2018
NICE appraisals process oncology drugs

The new NICE oncology appraisal process aims to enable fast-track appraisals, allowing earlier acces...

Read more
Publications
13.09.2018
Market Access Training Capabilities

How the pharmaceutical industry is investing in market access training capabilities to address today...

Read more
Articles
11.09.2018
NICE providing access to CAR-T therapy

Earlier this year, the UK government announced support for three new specialist centres capable of c...

Read more
Publications
06.09.2018
NICE appraisals process for oncology indications

Since 29th July 2016 the NICE appraisal process for oncology indications in England has been modifie...

Read more
Articles
29.08.2018
Brexit pharmaceutical market access and the UK

With eight months left before the UK leaves the EU in March 2019, it was hoped that a clear strategy...

Read more
Publications
22.08.2018
Biosimilar market access considerations

Purpose of this study was to understand the EU member state' local market access needs in relation t...

Read more
Articles
17.08.2018
Biosimilars Price Controls

The government has launched a consultation that outlines the proposed changes to its price controls ...

Read more
Articles
25.07.2018
EU-wide HTA clinical assessment

The European Commission (EC) has recently set out its draft proposal for adopting an EU-wide health...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.